Australia (AU)

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Evidence of a genetic link between endometriosis and ovarian cancer (2016) Lee AW, Templeman C, Stram DA, Beesley J, Tyrer J, Berchuck A, Pharoah PP, et al. Journal article Photonic-chip based widely tunable microwave source using a Brillouin opto-electronic oscillator (2016) Merklein M, Stiller B, Kabakova IV, Mutugala US, Vu K, Madden SJ, Eggleton BJ, Slavík R Conference contribution SUDAS: mmWave relaying for 5G outdoor-to-indoor communications (2016) Breiling M, Ng DWK, Rohde C, Burkhardt F, Schober R Book chapter / Article in edited volumes The Gamma-ray Cherenkov Telescope, an end-to end Schwarzschild-Couder telescope prototype proposed for the Cherenkov Telescope Array (2016) Dournaux JL, Abchiche A, Allan D, Amans JP, Armstrong TP, Balzer A, Berge D, et al. Conference contribution A man's blessing or a woman's curse? The Family-earnings gap of doctors (2016) Kühnle D, Schurer S, Cheng T, Scott A Journal article, Original article Nanoscale Characterization of Carrier Dynamic and Surface Passivation in InGaN/GaN Multiple Quantum Wells on GaN Nanorods (2016) Chen W, Wen X, Latzel M, Heilmann M, Yang J, Dai X, Huang S, et al. Journal article Secukinumab Provides Sustained Improvements in the Signs and Symptoms of Active Psoriatic Arthritis through 3 Years: Efficacy and Safety Results from a Phase 3 Trial (2016) Mease PJ, Kavanaugh A, Reimold A, Tahir H, Rech J, Hall S, Geusens P, et al. Conference contribution SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS OF ACTIVE PSORIATIC ARTHRITIS: 2-YEAR EFFICACY AND SAFETY RESULTS FROM THE PHASE 3 RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, FUTURE 1 (2016) Kavanaugh A, Mease P, Reimold A, Tahir H, Rech J, Hall S, Geusens P, et al. Conference contribution Long-Term (156-Week) Safety Profile of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Pooled Safety Analysis of 3 Phase III, Randomized, Controlled Trials (2016) Mease PJ, Gladman DD, Gomez-Reino JJ, Hall S, Kavanaugh A, Lespessailles E, Schett G, et al. Conference contribution THE EUROPEAN SOCIAL PREFERENCE MEASUREMENT (ESPM) STUDY: CONCEPTUAL CONSIDERATIONS AND IMPLEMENTATION (2016) Schlander M, Telser H, Holm S, Marshall DA, Nord E, Richardson J, Garattini S, et al. Conference contribution